EMvision Medical Devices Ltd
ASX:EMV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
EMvision Medical Devices Ltd
ASX:EMV
|
AU |
|
HLS Therapeutics Inc
TSX:HLS
|
CA |
|
Visionflex Group Ltd
ASX:VFX
|
AU |
|
C
|
C3is Inc
NASDAQ:CISS
|
GR |
|
Oncolytics Biotech Inc
TSX:ONC
|
CA |
|
Insulet Corp
NASDAQ:PODD
|
US |
|
C
|
Captivision Inc
NASDAQ:CAPT
|
UK |
|
BCE Inc
TSX:BCE
|
CA |
|
O'Reilly Automotive Inc
NASDAQ:ORLY
|
US |
|
S
|
SYSteel Tech Co Ltd
KOSDAQ:365330
|
KR |
|
Nizhnekamskshina PAO
MOEX:NKSH
|
RU |
|
Sarimelati Kencana Tbk PT
IDX:PZZA
|
ID |
|
Dian Swastatika Sentosa Tbk PT
IDX:DSSA
|
ID |
Wall Street
Price Targets
EMV Price Targets Summary
EMvision Medical Devices Ltd
According to Wall Street analysts, the average 1-year price target for
EMV
is 3.21 AUD
with a low forecast of 3.18 AUD and a high forecast of 3.31 AUD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EMV's stock price target?
Price Target
3.21
AUD
According to Wall Street analysts, the average 1-year price target for
EMV
is 3.21 AUD
with a low forecast of 3.18 AUD and a high forecast of 3.31 AUD.
What is EMvision Medical Devices Ltd's Revenue forecast?
Projected CAGR
15%
For the last 6 years the
compound annual growth rate for
EMvision Medical Devices Ltd's revenue is
31%.
The projected
CAGR
for the next 3 years is
15%.
